Somru BioScience Inc.

Somru BioScience Inc. is a leading biotechnology research organization dedicated to redefining drug development through technology-driven and AI-powered solutions. Operating at the cutting edge of innovation, Somru BioScience partners with pharmaceutical and biotech companies, supporting them across all phases of development with advanced scientific methods and platforms. The company's primary address is 19 Innovation Way, BioCommons Research Park, Charlottetown, Prince Edward Island C1E 0B7, CA, with an additional location at 40 York Rd, Towson, Maryland 21204, US.

At the heart of Somru BioScience Inc.'s offerings is Aegyris, an AI-driven platform that streamlines and optimizes data analysis, accelerating critical decision-making processes. Complementing this, Amplatto provides ultrasensitive analytical capabilities for precise quantification and detection of therapeutic molecules. Intelli.b, a revolutionary biologics fingerprinting solution, delivers unparalleled insights into molecular characteristics, particularly valuable in biosimilar and biologics development.

Somru BioScience Inc. offers an extensive range of services, including pharmacokinetics (PK), immunogenicity, biomarker analysis, and cell-based assays. With expertise in assay development, validation, and sample analysis under non-GLP, GLP, and GCP standards, Somru BioScience Inc. is committed to scientific excellence, data integrity, and regulatory compliance. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further enhance Somru BioScience Inc.'s visibility.